BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 27846148)

  • 1. 4-Methylumbelliferone Suppresses Hyaluronan Synthesis and Tumor Progression in SCID Mice Intra-abdominally Inoculated With Pancreatic Cancer Cells.
    Nagase H; Kudo D; Suto A; Yoshida E; Suto S; Negishi M; Kakizaki I; Hakamada K
    Pancreas; 2017 Feb; 46(2):190-197. PubMed ID: 27846148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Methylumbelliferone Decreases the Hyaluronan-rich Extracellular Matrix and Increases the Effectiveness of 5-Fluorouracil.
    Yoshida E; Kudo D; Nagase H; Suto A; Shimoda H; Suto S; Kakizaki I; Endo M; Hakamada K
    Anticancer Res; 2018 Oct; 38(10):5799-5804. PubMed ID: 30275202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors.
    Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS
    Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effects of 4-methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor.
    Ikuta K; Ota T; Zhuo L; Urakawa H; Kozawa E; Hamada S; Kimata K; Ishiguro N; Nishida Y
    Int J Cancer; 2017 Jan; 140(2):469-479. PubMed ID: 27706810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo.
    Urakawa H; Nishida Y; Wasa J; Arai E; Zhuo L; Kimata K; Kozawa E; Futamura N; Ishiguro N
    Int J Cancer; 2012 Jan; 130(2):454-66. PubMed ID: 21387290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-methylumbelliferone leads to growth arrest and apoptosis in canine mammary tumor cells.
    Saito T; Tamura D; Nakamura T; Makita Y; Ariyama H; Komiyama K; Yoshihara T; Asano R
    Oncol Rep; 2013 Jan; 29(1):335-42. PubMed ID: 23124556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase of Tumor Infiltrating γδ T-cells in Pancreatic Ductal Adenocarcinoma Through Remodeling of the Extracellular Matrix by a Hyaluronan Synthesis Suppressor, 4-Methylumbelliferone.
    Suto A; Kudo D; Yoshida E; Nagase H; Suto S; Mimura J; Itoh K; Hakamada K
    Pancreas; 2019 Feb; 48(2):292-298. PubMed ID: 30589828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
    Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
    Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis.
    Twarock S; Freudenberger T; Poscher E; Dai G; Jannasch K; Dullin C; Alves F; Prenzel K; Knoefel WT; Stoecklein NH; Savani RC; Homey B; Fischer JW
    Mol Cancer; 2011 Mar; 10():30. PubMed ID: 21429221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma.
    Cho H; Matsumoto S; Fujita Y; Kuroda A; Menju T; Sonobe M; Kondo N; Torii I; Nakano T; Lara PN; Gandara DR; Date H; Hasegawa S
    J Thorac Oncol; 2017 Mar; 12(3):477-490. PubMed ID: 27867002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan stimulates pancreatic cancer cell motility.
    Cheng XB; Kohi S; Koga A; Hirata K; Sato N
    Oncotarget; 2016 Jan; 7(4):4829-40. PubMed ID: 26684359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer.
    Koltai T; Reshkin SJ; Carvalho TMA; Cardone RA
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronan synthesis is required for IL-2-mediated T cell proliferation.
    Mahaffey CL; Mummert ME
    J Immunol; 2007 Dec; 179(12):8191-9. PubMed ID: 18056362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of 4-methylesculetin on hyaluronan synthesis slows the development of human pancreatic cancer in vitro and in nude mice.
    Hajime M; Shuichi Y; Makoto N; Masanori Y; Ikuko K; Atsushi K; Mutsuo S; Keiichi T
    Int J Cancer; 2007 Jun; 120(12):2704-9. PubMed ID: 17354230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hyaluronic acid inhibitor 4-methylumbelliferone is an NSMase2 activator-role of Ceramide in MU anti-tumor activity.
    Qin J; Kilkus J; Dawson G
    Biochim Biophys Acta; 2016 Feb; 1861(2):78-90. PubMed ID: 26548718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells.
    Twarock S; Tammi MI; Savani RC; Fischer JW
    J Biol Chem; 2010 Jul; 285(30):23276-84. PubMed ID: 20463012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice.
    Piccioni F; Malvicini M; Garcia MG; Rodriguez A; Atorrasagasti C; Kippes N; Piedra Buena IT; Rizzo MM; Bayo J; Aquino J; Viola M; Passi A; Alaniz L; Mazzolini G
    Glycobiology; 2012 Mar; 22(3):400-10. PubMed ID: 22038477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells.
    Lokeshwar VB; Lopez LE; Munoz D; Chi A; Shirodkar SP; Lokeshwar SD; Escudero DO; Dhir N; Altman N
    Cancer Res; 2010 Apr; 70(7):2613-23. PubMed ID: 20332231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of hyaluronan synthesis attenuates the tumorigenicity of low-grade chondrosarcoma.
    Hamada S; Nishida Y; Zhuo L; Shinomura T; Ikuta K; Arai E; Koike H; Kimata K; Ushida T; Ishiguro N
    J Orthop Res; 2018 Jun; 36(6):1573-1580. PubMed ID: 29091320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of hyaluronan synthase inhibitor, 4-methylumbelliferone derivatives on human pancreatic cancer cell (KP1-NL).
    Morohashi H; Kon A; Nakai M; Yamaguchi M; Kakizaki I; Yoshihara S; Sasaki M; Takagaki K
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1454-9. PubMed ID: 16730656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.